Market Overview:
The global antiepileptic drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of epilepsy, rising geriatric population, and growing demand for novel antiepileptic drugs. Based on type, the global antiepileptic drugs market is segmented into partial and generalized seizures. Partial seizures are further classified into simple and complex partial seizures. Generalized seizures are further classified into tonic-clonic (grand mal), absence (petit mal), atonic (drop attack), myoclonic, and clonic seizures. Based on application, the global antiepileptic drugs market is segmented into retail pharmacies, hospitals pharmacies, drug-stores, online stores/pharmacies,. Geographically,, North America dominates the global Antiepileptic Drugs Market followed by Europe due States owing to high incidence rate of epilepsy in these regions .
Product Definition:
Antiepileptic drugs are medications used to prevent and control seizures. They are the mainstay of treatment for epilepsy, a disorder in which individuals have recurrent seizures. While antiepileptic drugs cannot cure epilepsy, they can reduce the frequency and severity of seizures, making it possible for people with epilepsy to live normal lives.
Partial:
Partial seizures are a group of mild to severe electrical disruptions in the brain. Partial seizures may or may not lead to convulsions. They are responsible for causing changes in consciousness, perceptions, and memory. Epilepsy is considered as a disease wherein there are frequent and recurrent unprovoked seizures due to loss of awareness during the attack as well as muscle control problems (ataxia).
Generalized:
Epilepsy is a neurological disorder characterized by repeated unprovoked seizures. The incidence of epilepsy has been increasing over the past few decades and it is one of the most common neurological diseases in the world. According to WHO, approximately 50 million people are suffering from epilepsy worldwide which accounts for about 10% of all disabilities affecting population globally.
Application Insights:
Based on the application, the global antiepileptic drugs market is segmented into retail pharmacies, hospital pharmacies, online/mail-order pharmacies and drug stores. The retail pharmacy held the largest share of over 70.0% in 2017 owing to factors such as high patient awareness regarding epilepsy treatment and availability of a large number of healthcare professionals who are able to prescribe antiepileptic drugs (AEDs).
The hospitals were followed by drug stores in terms of revenue in 2017 due to presence of key players operating within this niche market such as Walgreens Boots Alliance, CVS Health Corporation and Rite Aid Corporation that have been providing AEDs for free through their charity programs.
Regional Analysis:
North America dominated the global market in 2017, with a revenue share of over 50.0%. Key factors contributing to its large share include the presence of key manufacturers and research & development facilities in this region. Moreover, high prevalence of epilepsy coupled with favorable government initiatives is expected to drive regional growth during the forecast period. For instance, according to data published by Epilepsy Foundation in 2018, around 30 million people suffer from epilepsy and approximately 2 million new cases are diagnosed annually in U.S., which results into increased demand for antiepileptic drugs (AEDs).
Growth Factors:
- Increasing incidence of epilepsy: The global incidence of epilepsy is estimated to be around 50 million, and the number of people with epilepsy is projected to reach more than 75 million by 2030. This growing population is expected to drive the demand for antiepileptic drugs in the coming years.
- Rising awareness about epileptic seizures and their treatment: There is a growing awareness among people about epileptic seizures and their treatment options. This is likely to boost the demand for antiepileptic drugs in the near future.
- Technological advancements in antiepileptic drug development: The pharmaceutical industry has been making significant advances in the development of new antiepileptic drugs, which are more effective and have fewer side effects than older medications. This trend is likely to fuel market growth over the next few years.
- Growing use of combination therapies: A growing number of patients are now being treated with combination therapies that include two or more different types of antiepileptic drugs simultaneously. This trend is expected to contribute significantly to market growth over the next few years . 5) Expanding product pipeline: The pharmaceutical companies are currently focusing on expanding their product pipelines by developing new molecules that can be used as potential treatments for epilepsy
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiepileptic Drugs Market Research Report
By Type
Partial, Generalized
By Application
Retail Pharmacies, Hospitals Pharmacies, Drug-store, Online
By Companies
Abbott Laboratories, Cephalon, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi, UCB Pharma, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Antiepileptic Drugs Market Report Segments:
The global Antiepileptic Drugs market is segmented on the basis of:
Types
Partial, Generalized
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacies, Hospitals Pharmacies, Drug-store, Online
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Cephalon
- Sunovion Pharmaceuticals
- Valeant Pharmaceuticals International
- Sanofi
- UCB Pharma
- GlaxoSmithKline
- Johnson & Johnson
- Novartis
- Pfizer
Highlights of The Antiepileptic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Partial
- Generalized
- By Application:
- Retail Pharmacies
- Hospitals Pharmacies
- Drug-store
- Online
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiepileptic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antiepileptic drugs (AEDs) are medications used to control seizures. AEDs work by reducing the number, duration, or severity of seizures.
Some of the key players operating in the antiepileptic drugs market are Abbott Laboratories, Cephalon, Sunovion Pharmaceuticals, Valeant Pharmaceuticals International, Sanofi, UCB Pharma, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer.
The antiepileptic drugs market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antiepileptic Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antiepileptic Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antiepileptic Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antiepileptic Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antiepileptic Drugs Market Size & Forecast, 2018-2028
4.5.1 Antiepileptic Drugs Market Size and Y-o-Y Growth
4.5.2 Antiepileptic Drugs Market Absolute $ Opportunity
Chapter 5 Global Antiepileptic Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antiepileptic Drugs Market Size Forecast by Type
5.2.1 Partial
5.2.2 Generalized
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antiepileptic Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antiepileptic Drugs Market Size Forecast by Applications
6.2.1 Retail Pharmacies
6.2.2 Hospitals Pharmacies
6.2.3 Drug-store
6.2.4 Online
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antiepileptic Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antiepileptic Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antiepileptic Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Antiepileptic Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antiepileptic Drugs Market Size Forecast by Type
9.6.1 Partial
9.6.2 Generalized
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antiepileptic Drugs Market Size Forecast by Applications
9.10.1 Retail Pharmacies
9.10.2 Hospitals Pharmacies
9.10.3 Drug-store
9.10.4 Online
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antiepileptic Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Antiepileptic Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antiepileptic Drugs Market Size Forecast by Type
10.6.1 Partial
10.6.2 Generalized
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antiepileptic Drugs Market Size Forecast by Applications
10.10.1 Retail Pharmacies
10.10.2 Hospitals Pharmacies
10.10.3 Drug-store
10.10.4 Online
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antiepileptic Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antiepileptic Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antiepileptic Drugs Market Size Forecast by Type
11.6.1 Partial
11.6.2 Generalized
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antiepileptic Drugs Market Size Forecast by Applications
11.10.1 Retail Pharmacies
11.10.2 Hospitals Pharmacies
11.10.3 Drug-store
11.10.4 Online
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antiepileptic Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Antiepileptic Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antiepileptic Drugs Market Size Forecast by Type
12.6.1 Partial
12.6.2 Generalized
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antiepileptic Drugs Market Size Forecast by Applications
12.10.1 Retail Pharmacies
12.10.2 Hospitals Pharmacies
12.10.3 Drug-store
12.10.4 Online
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antiepileptic Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antiepileptic Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antiepileptic Drugs Market Size Forecast by Type
13.6.1 Partial
13.6.2 Generalized
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antiepileptic Drugs Market Size Forecast by Applications
13.10.1 Retail Pharmacies
13.10.2 Hospitals Pharmacies
13.10.3 Drug-store
13.10.4 Online
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antiepileptic Drugs Market: Competitive Dashboard
14.2 Global Antiepileptic Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Cephalon
14.3.3 Sunovion Pharmaceuticals
14.3.4 Valeant Pharmaceuticals International
14.3.5 Sanofi
14.3.6 UCB Pharma
14.3.7 GlaxoSmithKline
14.3.8 Johnson & Johnson
14.3.9 Novartis
14.3.10 Pfizer
